PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
Nvidia outlook 2024: backlog, Vera Rubin AI chips, partnerships, 73% margins and 24x forward P/E—key upside drivers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback